Evidence map›Paper›PMID 12952521›Full record

ArticleThe Biochemical journal2003

Processing of N-linked glycans during endoplasmic-reticulum-associated degradation of a short-lived variant of ribophorin I.

Claudia Kitzmüller, Andrea Caprini, Stuart E H Moore, Jean-Pierre Frénoy, Eva Schwaiger, Odile Kellermann, N Erwin Ivessa, Myriam Ermonval

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. A luminal flavoprotein in endoplasmic reticulum-associated degradation.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  8. Article
  9. Article
  10. SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Claudia KitzmüllerMax F. Perutz Laboratories, University Departments at the Vienna Biocenter and Institute of Medical Biochemistry, Department of Molecular Genetics, University of Vienna, Austria.
Andrea Caprini
Stuart E H Moore
Jean-Pierre Frénoy
Eva Schwaiger
Odile Kellermann
N Erwin Ivessa
Myriam Ermonval
Inserm · FRInstitut Pasteur · FRMax Perutz Labs · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the role of N-linked glycans in the process of ERAD (endoplasmic reticulum-associated degradation) of proteins has been widely recognized. In the present study, we attempted to delineate further the sequence of events leading from a fully glycosylated soluble protein to its deglycosylated form. Degradation intermediates of a truncated form of ribophorin I, namely RI(332), which contains a single N-linked oligosaccharide and is a substrate for the ERAD/ubiquitin-proteasome pathway, were characterized in HeLa cells under conditions blocking proteasomal degradation. The action of a deoxymannojirimycin- and kifunensine-sensitive alpha1,2-mannosidase was shown here to be required for both further glycan processing and progression of RI(332) in the ERAD pathway. In a first step, the Man(8) isomer B, generated by ER mannosidase I, appears to be the major oligomannoside structure associated with RI(332) intermediates. Some other trimmed N-glycan species, in particular Glc(1)Man(7)GlcNAc(2), were also found on the protein, indicating that several mannosidases might be implicated in the initial trimming of the oligomannoside. Secondly, another intermediate of degradation of RI(332) accumulated after proteasome inhibition. We demonstrated that this completely deglycosylated form arose from the action of an N-glycanase closely linked to the ER membrane. Indeed, the deglycosylated form of the protein remained membrane-associated, while being accessible from the cytoplasm to ubiquitinating enzymes and to added protease. Our results indicate that deglycosylation of a soluble ERAD substrate glycoprotein occurs in at least two distinct steps and is coupled with the retro-translocation of the protein preceding its proteasomal degradation.

Indexed as

Cysteine EndopeptidasesCytosolEndoplasmic ReticulumGlycoside HydrolasesGlycosylationHeLa CellsHumansKineticsMannoseMannosidasesMembrane ProteinsMultienzyme ComplexesPolysaccharidesProteasome Endopeptidase ComplexProtein TransportCysteine EndopeptidasesglycanaseGlycoside HydrolasesMannoseMannosidasesMembrane ProteinsMultienzyme ComplexesPolysaccharidesProteasome Endopeptidase Complexribophorin

Identifiers

PMID12952521
PMCPMC1223801
OpenAlexW2036406080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.